Type 2 Diabetes

Why trials studying Type 2 Diabetes stopped, in this sample of ClinicalTrials.gov.

22 stopped trials with a clear reason; 82% ended for non-scientific reasons.

Trials

• Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm
  NCT07066891 · TERMINATED · logistics pi
  “Recruitment was stopped early because hospital length-of-stay constraints limited protocol delivery. The PI's decision also took account of the available non-inferiority results.”
• Polypill Versus Metformin in New Onset Type 2 Diabetes
  NCT05833958 · WITHDRAWN · funding business
  “The sponsor has determined that this study will be postponed due to changing business priorities.”
• Evaluation of Exercise Application Technology in Adolescents
  NCT05720377 · WITHDRAWN · funding business
  “Funding not obtained”
• Identification of Human Biomarkers Predictive of Diabetes Remission in Type 2 Diabetes Patient (BARIAKINES)
  NCT05472883 · TERMINATED · slow accrual
  “Inclusion difficulties”
• Probiotic on Type 2 Diabetes and Chronic Obstruction Pulmonary Disease
  NCT05492448 · TERMINATED · funding business
  “Insufficient funds”
• A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes
  NCT04667182 · WITHDRAWN · funding business
  “Study was withdrawn prior to enrolment due to business decision.”
• Exercise Training as an Intervention to Improve Muscle Function and Recovery Following Bed Rest in Older Adults With Type 2 Diabetes
  NCT04057677 · TERMINATED · funding business
  “Insufficient funds.”
• Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
  NCT02198209 · WITHDRAWN · funding business
  “Investigator decided not to move forward with study prior to study start date”
• Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years
  NCT02639988 · TERMINATED · funding business
  “Given the number of patients included in the cross-sectional analysis and the lack of financial resources, it was decided to focus on cross-sectional data.”
• An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus
  NCT02324491 · TERMINATED · funding business
  “Sponsor decision to analyze available safety and efficacy data”
• Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI
  NCT02263677 · WITHDRAWN · logistics pi
  “Technical difficulties have caused this study to be terminated”
• forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)
  NCT01944618 · TERMINATED · other
  “Participant Data obtained to 30Sep2015: Baseline data: 447 6 month data: 253 Program terminated: recruitment target not met. No analysis will be provided.”
• Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
  NCT02721888 · TERMINATED · slow accrual
  “Failure of inclusion”
• Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding
  NCT01597531 · TERMINATED · slow accrual
  “Difficulty recruiting patients”
• A Pharmacodynamic Study of Measured Glomerular Filtration Rate in Patients With Chronic Kidney Disease and Type 2 Diabetes
  NCT01500798 · TERMINATED · safety
  “IDMC recommendation for safety concerns”
• Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM
  NCT00732147 · WITHDRAWN · funding business
  “Sponsor could not fund.”
• VA NEPHRON-D: Diabetes iN Nephropathy Study
  NCT00555217 · TERMINATED · safety
  “It was stopped primarily because of safety concerns along with low conditional power to detect a treatment effect on the primary outcome.”
• Central Mechanisms That Regulate Glucose Metabolism in Humans
  NCT01028846 · TERMINATED · regulatory
  “IRB approval expired 6/13/2023. Primary Completion Date and Study Completion Date updated after definitions were explained to PI/study team. Study never reached intended enrollment and will be categorized as terminated.”
• Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics Study
  NCT00362765 · TERMINATED · slow accrual
  “The study was prematurely terminated, due to difficulties in the recruitment of T2DM patients who are not under statin therapy at inclusion.”
• The Genetics of Diabetes in Southern California Chinese Americans
  NCT00824395 · WITHDRAWN · other
  “Non applicable clinical trial”
• GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
  NCT00252876 · TERMINATED · funding business
  “The development program has been terminated”
• Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes
  NCT00627783 · TERMINATED · slow accrual
  “Poor recruiting status”

Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.